WO2015170286A3 - Modulation of blood glucose levels - Google Patents

Modulation of blood glucose levels Download PDF

Info

Publication number
WO2015170286A3
WO2015170286A3 PCT/IB2015/053360 IB2015053360W WO2015170286A3 WO 2015170286 A3 WO2015170286 A3 WO 2015170286A3 IB 2015053360 W IB2015053360 W IB 2015053360W WO 2015170286 A3 WO2015170286 A3 WO 2015170286A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood glucose
glucose levels
modulation
diabetes
compositions
Prior art date
Application number
PCT/IB2015/053360
Other languages
French (fr)
Other versions
WO2015170286A2 (en
Inventor
Sai Ying Ko
Original Assignee
Biolingus Ip Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014901695A external-priority patent/AU2014901695A0/en
Application filed by Biolingus Ip Llc filed Critical Biolingus Ip Llc
Publication of WO2015170286A2 publication Critical patent/WO2015170286A2/en
Publication of WO2015170286A3 publication Critical patent/WO2015170286A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention provides methods and compositions for modulating blood glucose levels, and methods and compositions for use in the treatment of diabetes, in particular type 2 diabetes.
PCT/IB2015/053360 2014-05-08 2015-05-08 Modulation of blood glucose levels WO2015170286A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2014901695 2014-05-08
AU2014901695A AU2014901695A0 (en) 2014-05-08 Modulation of blood glucose levels

Publications (2)

Publication Number Publication Date
WO2015170286A2 WO2015170286A2 (en) 2015-11-12
WO2015170286A3 true WO2015170286A3 (en) 2016-01-28

Family

ID=54251539

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/053360 WO2015170286A2 (en) 2014-05-08 2015-05-08 Modulation of blood glucose levels

Country Status (1)

Country Link
WO (1) WO2015170286A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016168388A2 (en) 2015-04-14 2016-10-20 Palatin Technologies, Inc. Therapies for obesity, diabetes and related indications
EP3589271A4 (en) * 2017-02-28 2021-01-06 Biolingus IP LLC Oil based formulations for sublingual and buccal delivery

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009080032A1 (en) * 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising a systemically active small peptide
EP2389945A1 (en) * 2010-05-28 2011-11-30 Sanofi-Aventis Deutschland GmbH Pharmaceutical composition comprising AVE0010 and insulin glargine
WO2012109694A1 (en) * 2011-02-18 2012-08-23 Sai Ying Ko Process for preparing products comprising stabilised actives and compositions comprising same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
AUPR272901A0 (en) 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009080032A1 (en) * 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising a systemically active small peptide
EP2389945A1 (en) * 2010-05-28 2011-11-30 Sanofi-Aventis Deutschland GmbH Pharmaceutical composition comprising AVE0010 and insulin glargine
WO2012109694A1 (en) * 2011-02-18 2012-08-23 Sai Ying Ko Process for preparing products comprising stabilised actives and compositions comprising same

Also Published As

Publication number Publication date
WO2015170286A2 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
WO2016172658A3 (en) Microbiome regulators and related uses thereof
EP3675714A4 (en) Devices and methods for vascular navigation, assessment and/or diagnosis
WO2016100985A3 (en) Chimeric antigen receptors and methods of use thereof
EA201270803A1 (en) TIOACATETIC COMPOUNDS, COMPOSITIONS ON THEIR BASIS AND METHODS OF THEIR APPLICATION
EP3095855A4 (en) Efficient bottom treatment bacillus, composite bottom treatment inoculant prepared using same and applications thereof
EA201790434A1 (en) CHANNEL MODULATORS
WO2013158844A3 (en) Color correcting compositions and methods of use thereof
WO2015179559A3 (en) Pyrazole compounds and methods of making and using same
WO2017023933A3 (en) Peptidomimetic macrocycles
EP3297641A4 (en) Methods for the storage of whole blood, and compositions thereof
WO2015191951A3 (en) Modulation of complement activity
EP3411504A4 (en) Anti-tnf antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
EP3451908A4 (en) Devices and methods for vascular navigation, assessment and/or diagnosis
MX2018000352A (en) Substituted 4-azaindoles and their use as glun2b receptor modulators.
PH12018500887A1 (en) Anti-htra1 antibodies and methods of use thereof
WO2017087916A3 (en) Thermostable glucose biosensors and uses thereof
MX2018002543A (en) Compositions comprising urolithin compounds.
WO2016014342A3 (en) Ang-(1-7) derviative oligopeptides and methods for using and producing the same
MX2018002546A (en) Compositions comprising an urolithin compound.
WO2013120022A3 (en) Treatment of hypoglycemia
WO2016007540A3 (en) Compositions and methods for treating dengue virus infection
MX2018005987A (en) Heterocyclic compounds for the treatment of disease.
WO2018189661A3 (en) Methods and compounds for treating diabetes
WO2015170286A3 (en) Modulation of blood glucose levels
WO2016135456A3 (en) A gm-csf negative modulator for use in treating, preventing or ameliorating aortopathy

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15774966

Country of ref document: EP

Kind code of ref document: A2